LaFauci G - Search Results

1

A Genotype-Phenotype Study of High-Resolution FMR1 Nucleic Acid and Protein Analyses in Fragile X Patients with Neurobehavioral Assessments.

Budimirovic DB, Schlageter A, Filipovic-Sadic S, Protic DD, Bram E, Mahone EM, Nicholson K, Culp K, Javanmardi K, Kemppainen J, Hadd A, Sharp K, Adayev T, LaFauci G, Dobkin C, Zhou L, Brown WT, Berry-Kravis E, Kaufmann WE, Latham GJ. Budimirovic DB, et al. Among authors: lafauci g. Brain Sci. 2020 Sep 30;10(10):694. doi: 10.3390/brainsci10100694. Brain Sci. 2020. PMID: 33008014 Free PMC article.

2

Fragile X screening by quantification of FMRP in dried blood spots by a Luminex immunoassay.

LaFauci G, Adayev T, Kascsak R, Kascsak R, Nolin S, Mehta P, Brown WT, Dobkin C. LaFauci G, et al. J Mol Diagn. 2013 Jul;15(4):508-17. doi: 10.1016/j.jmoldx.2013.02.006. Epub 2013 May 7. J Mol Diagn. 2013. PMID: 23660422 Free article.

3

Detection and Quantification of the Fragile X Mental Retardation Protein 1 (FMRP).

LaFauci G, Adayev T, Kascsak R, Brown WT. LaFauci G, et al. Genes (Basel). 2016 Dec 9;7(12):121. doi: 10.3390/genes7120121. Genes (Basel). 2016. PMID: 27941672 Free PMC article. Review.

4

Reduced vagal tone in women with the FMR1 premutation is associated with FMR1 mRNA but not depression or anxiety.

Klusek J, LaFauci G, Adayev T, Brown WT, Tassone F, Roberts JE. Klusek J, et al. Among authors: lafauci g. J Neurodev Disord. 2017 May 2;9:16. doi: 10.1186/s11689-017-9197-6. eCollection 2017. J Neurodev Disord. 2017. PMID: 28469730 Free PMC article.

5

Development of a Quantitative FMRP Assay for Mouse Tissue Applications.

Adayev T, LaFauci G, Xu W, Dobkin C, Kascsak R, Brown WT, Goodman JH. Adayev T, et al. Among authors: lafauci g. Genes (Basel). 2021 Sep 26;12(10):1516. doi: 10.3390/genes12101516. Genes (Basel). 2021. PMID: 34680911 Free PMC article.

6

Prospects for gene therapy in the fragile X syndrome.

Rattazzi MC, LaFauci G, Brown WT. Rattazzi MC, et al. Among authors: lafauci g. Ment Retard Dev Disabil Res Rev. 2004;10(1):75-81. doi: 10.1002/mrdd.20012. Ment Retard Dev Disabil Res Rev. 2004. PMID: 14994292 Review.

7

Fragile X protein in newborn dried blood spots.

Adayev T, LaFauci G, Dobkin C, Caggana M, Wiley V, Field M, Wotton T, Kascsak R, Nolin SL, Glicksman A, Hosmer N, Brown WT. Adayev T, et al. Among authors: lafauci g. BMC Med Genet. 2014 Oct 28;15:119. doi: 10.1186/s12881-014-0119-0. BMC Med Genet. 2014. PMID: 25348928 Free PMC article.

8

Tissue and developmental regulation of fragile X mental retardation 1 exon 12 and 15 isoforms.

Xie W, Dolzhanskaya N, LaFauci G, Dobkin C, Denman RB. Xie W, et al. Among authors: lafauci g. Neurobiol Dis. 2009 Jul;35(1):52-62. doi: 10.1016/j.nbd.2009.03.015. Epub 2009 Apr 9. Neurobiol Dis. 2009. PMID: 19362146

9

The role of reduced expression of fragile X mental retardation protein in neurons and increased expression in astrocytes in idiopathic and syndromic autism (duplications 15q11.2-q13).

Wegiel J, Brown WT, La Fauci G, Adayev T, Kascsak R, Kascsak R, Flory M, Kaczmarski W, Kuchna I, Nowicki K, Martinez-Cerdeno V, Wisniewski T, Wegiel J. Wegiel J, et al. Autism Res. 2018 Oct;11(10):1316-1331. doi: 10.1002/aur.2003. Epub 2018 Aug 14. Autism Res. 2018. PMID: 30107092

10

Optimization, validation and initial clinical implications of a Luminex-based immunoassay for the quantification of Fragile X Protein from dried blood spots.

Boggs AE, Schmitt LM, McLane RD, Adayev T, LaFauci G, Horn PS, Dominick KC, Gross C, Erickson CA. Boggs AE, et al. Among authors: lafauci g. Sci Rep. 2022 Apr 4;12(1):5617. doi: 10.1038/s41598-022-09633-8. Sci Rep. 2022. PMID: 35379866 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page